1. Home
  2. OSUR vs PHLT Comparison

OSUR vs PHLT Comparison

Compare OSUR & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSUR
  • PHLT
  • Stock Information
  • Founded
  • OSUR 2000
  • PHLT 1976
  • Country
  • OSUR United States
  • PHLT United States
  • Employees
  • OSUR N/A
  • PHLT N/A
  • Industry
  • OSUR Medical/Dental Instruments
  • PHLT Other Consumer Services
  • Sector
  • OSUR Health Care
  • PHLT Consumer Discretionary
  • Exchange
  • OSUR Nasdaq
  • PHLT Nasdaq
  • Market Cap
  • OSUR 223.0M
  • PHLT 267.0M
  • IPO Year
  • OSUR 1986
  • PHLT N/A
  • Fundamental
  • Price
  • OSUR $3.06
  • PHLT $4.16
  • Analyst Decision
  • OSUR Hold
  • PHLT
  • Analyst Count
  • OSUR 1
  • PHLT 0
  • Target Price
  • OSUR $3.00
  • PHLT N/A
  • AVG Volume (30 Days)
  • OSUR 783.1K
  • PHLT 202.2K
  • Earning Date
  • OSUR 08-05-2025
  • PHLT 08-06-2025
  • Dividend Yield
  • OSUR N/A
  • PHLT N/A
  • EPS Growth
  • OSUR N/A
  • PHLT N/A
  • EPS
  • OSUR N/A
  • PHLT N/A
  • Revenue
  • OSUR $161,626,000.00
  • PHLT $128,916,000.00
  • Revenue This Year
  • OSUR N/A
  • PHLT $11.03
  • Revenue Next Year
  • OSUR $6.20
  • PHLT $11.23
  • P/E Ratio
  • OSUR N/A
  • PHLT N/A
  • Revenue Growth
  • OSUR N/A
  • PHLT 11.76
  • 52 Week Low
  • OSUR $2.36
  • PHLT $2.17
  • 52 Week High
  • OSUR $4.92
  • PHLT $4.35
  • Technical
  • Relative Strength Index (RSI)
  • OSUR 57.98
  • PHLT N/A
  • Support Level
  • OSUR $2.92
  • PHLT N/A
  • Resistance Level
  • OSUR $3.08
  • PHLT N/A
  • Average True Range (ATR)
  • OSUR 0.14
  • PHLT 0.00
  • MACD
  • OSUR 0.01
  • PHLT 0.00
  • Stochastic Oscillator
  • OSUR 84.85
  • PHLT 0.00

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About PHLT Performant Healthcare Inc. Common Stock

Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.

Share on Social Networks: